健康 Imugene异体CAR-T疗法Azer-cel在DLBCL试验中显现75%总缓解率 editorial 15 7 月, 2025 悉尼——临床阶段免疫肿瘤学公司Imuge... Read MoreRead more about Imugene异体CAR-T疗法Azer-cel在DLBCL试验中显现75%总缓解率